Navigation Links
United Nations Urged to Ban Mercury in Vaccines
Date:4/6/2011

SILVER SPRING, Md., April 6, 2011 /PRNewswire-USNewswire/ -- CoMeD – While the United Nations (UN) actively questions the use of vaccines containing a neurotoxic mercury compound, the Coalition for Mercury-Free Drugs (CoMeD), a Maryland-based, non-profit organization, is urging the UN to ban it.

In mid-March, governments were asked to send the UN secretariat "information on mercury use in pharmaceuticals, especially vaccines."  The request was made in preparation for the United Nations Environmental Programme's third intergovernmental negotiating committee (INC3) on mercury, scheduled for this fall.  The purpose of the INC meetings is to develop a legally-binding, global mercury treaty by 2013.

CoMeD was pleased by this call for information because CoMeD provided scientific data about health hazards caused by mercury in vaccines to various international delegates at the second INC meeting in January in Chiba, Japan.

Since then, CoMeD has publicized new studies proving that the mercury in vaccines and dental amalgams, or "silver" fillings, is associated with neurological diseases such as autism in children and Alzheimer's disease in adults.

One study from the University of Brazil recognizes vaccines as essential but suggests that the use of Thimerosal, a mercury-based compound sometimes used as a vaccine preservative, be reconsidered.  Recent articles in Folia Neuropathologica, Middle East Current Psychiatry, the Journal of Immunotoxicology, the Journal of Occupational Medicine and Toxicology, and the Journal of Physiology and Pharmacology confirm the toxicity of the dose of mercury in Thimerosal-preserved vaccines.

In humans, Thimerosal is recognized to cause cancer, genetic mutations and birth defects.  In 1999, the U.S. Public Health Service and American Academy of Pediatrics jointly called for its removal from U.S. vaccines "as soon as possible."  Thimerosal has since been replaced by the much less toxic compounds, like 2-phenoxyethanol (2-PE), in preserved vaccines licensed for U.S. use by the FDA since 2001.  Though most doses contain Thimerosal, flu shots are now strongly recommended for pregnant women and children.

A CoMeD analysis has shown that replacing Thimerosal, a compound that is 50% bioaccumulative mercury by weight, with 2-phenoxyphenol in all vaccines, including the flu shot, is both economical and safer.  Additionally, CoMeD has sued the FDA for its failure to comply with the law and enforce preservative safety regulations.

Furthermore, vaccine-safety proponents are encouraging those who are responsible for international vaccination campaigns to heed the overwhelming evidence that human health risks are linked to mercury and other vaccine ingredients.  

Rev. Lisa K. Sykes, President of CoMeD, is warning groups including the Global Alliance for Vaccines, the United Nations Children's Fund (UNICEF), and the Bill and Melinda Gates Foundation to stop spreading mercury to other continents: "While Thimerosal has been removed from most vaccines in the United States, pharmaceutical companies and the World Health Organization continue to dump mercury-laced vaccines on developing countries.  No ethic can justify providing prosperous nations with mercury-free vaccines while endangering children in poor nations by exposing them to this neurotoxin."


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Philips to Take Orders for the Ingenia MRI System in the United States
2. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
3. Medicomp, Inc. Announces Company Purchase From United Therapeutics
4. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
5. Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes
6. "The State of the Medical Marijuana Markets 2011" First Ever Investor-Grade Analysis Report of the Marijuana Marketplace in the United States
7. American Scientific Resources Announces New Distributor Syner-Med Placing Kidz-Med VeraTemp in the United Kingdom and Ireland
8. BrainScope® Prepares to Introduce Ahead™ EU-100 to Aid in Assessment of Head Injury in the United Kingdom
9. Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lyn™ in the United States
10. LifeWatch Teams With UnitedHealthcare, The Largest Healthcare Insurer In The United States, As A Preferred National Provider Of Cardiac Monitoring Services To Reduce Patient Costs
11. Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Women's ... , Roberta Jordan is a Certified Nurse Midwife who was born and raised ... then went on to complete her masters degree from the University of Mexico. ...
(Date:5/24/2016)... ... 24, 2016 , ... Educational opportunities, and therefore life chances, ... communities providing richer opportunities. Recognizing the key role of housing in this system, ... school choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) housing-focused ...
(Date:5/24/2016)... ... 24, 2016 , ... Regenerative Medicine is being transformed by ongoing research and ... protocols and patient results as have been achieved with Okyanos Cell Therapy ... of care for patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies ... to its board of directors. Otterstatter is co-founder, president and CEO of ... technological innovations that lead to broad-based healthcare solutions. , “Jon knows how to ...
Breaking Medicine News(10 mins):